50% of the FDA's annual budget comes from industry application fees. Knowing that, who do you think has more financial leverage with the FDA? Amarin with it's one drug, or the Generic industry that files numerous ANDA's per year (with the appropriate fees).
The "government" in general LOVES generic drugs. Hikma/Reddy have far more lobby power than Amarin does. That's how shit works in this world.
So to answer your question... what would compel the FDA to even care at this point? It's been 5+ years. The Writ of Cert was denied. Amarin didnt even care enough to pursue it themselves, it was shareholders. You think the FDA does anything on their own without something like bad publicity of dead patients in the media, or drug substances found in supplements that infringes on their cartel control of the drug industry, or a large stakeholder (Amarin isnt) demanding action on something?
Market Data 
Markets 
AI
